Gary L Kanter

Gary L Kanter, M.D.

Associate Professor

Department: MD-PSYCHIATRY
Business Phone: (352) 265-4357
Business Email: kanter@ufl.edu

On This Page

About Gary L Kanter

After completion of his psychiatric residency, Dr. KanterĀ established his private practice of psychiatry in Gainesville, Florida in 1984. Dr. Kanter provided outpatient psychiatric services including psychodynamic psychotherapy, psychopharmacology,Ā consultation and supervision for thirty-three years. Ā Ā 

In June 2016 he joined the University of Florida College of Medicine Department of Psychiatry with the focus on the education of the psychiatric residents and the articulation of psychotherapyĀ and psychopharmacological skillsĀ within the outpatient clinical setting.

Accomplishments

  1. Faculty Leadership Development Award

    University of Florida, College of Medicine

  2. Carlos E. Muniz, MD Mentor Award

    Department of Psychiatry, University of Florida

Teaching Profile

Courses Taught

  1. MDT7840 – Elect Top/Psychiatry

    College of Medicine

Board Certifications

  • Distinguished Life Fellow
    American Psychiatric Association
  • Psychiatry
    American Board of Psychiatry and Neurology

Clinical Profile

Specialties

  • Psychiatry

Areas of Interest

  • Anorexia
  • Attention Deficit Hyperactivity Disorder
  • Binge Eating Disorder
  • Borderline Personality Disorder
  • Bulimia
  • Depression
  • Generalized Anxiety Disorder
  • Narcissistic Personality Disorder
  • Panic Disorder
  • Persistent Depressive Disorder
  • Suicide and Suicidal Behavior
  • Transcranial Magnetic Stimulation (TMS)

Grants

  1. A Multicenter, 48-week Open-Label Safety Study of Adjunctive Troriluzole in Subjects with Obsessive Compulsive Disorder

    Role:
    Principal Investigator
    Funding:
    COGNITIVE RESEARCH CORPORATION via BIOHAVEN PHARMACEUTICALS
  2. A Randomized, Double-Blind, Placebo-Controlled Trial of Adjunctive Troriluzole in Obsessive Compulsive Disorder

    Role:
    Principal Investigator
    Funding:
    BIOHAVEN PHARMACEUTICALS
  3. A randomized, double-blind, placebo-controlled trial of adjunctive BHV-4157 in Obsessive Compulsive Disorder

    Role:
    Principal Investigator
    Funding:
    BIOHAVEN PHARMACEUTICALS

Education

  1. Residency – Psychiatry

    University of Rochester School of Medicine, Strong Memorial Hospital

  2. Internship – Psychiatry

    University of Rochester School of Medicine, Strong Memorial Hospital

  3. Medical Degree

    University of Rochester School of Medicine

Contact Details

Phones:
Business:
(352) 265-4357
Emails:
Business:
kanter@ufl.edu
Addresses:
Business Mailing:
PO Box 103424
GAINESVILLE FL 32610
Business Street:
J256 JHMHC
GAINESVILLE FL 32611